ANISSA RAMIREZ: Open Payments
NPI 1003116740 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 45 payments from 14 companies in 2025. Trend: 2023 $669 · 2024 $1,067 · 2025 $897
Food & beverage: $880Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $241 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $80 |
| Lilly USA, LLC | 4 | $77 |
| SANOFI-AVENTIS U.S. LLC | 4 | $70 |
| Dynavax Technologies Corporation | 4 | $53 |
| Sumitomo Pharma America, Inc. | 3 | $45 |
| PFIZER INC. | 2 | $36 |
| Abbott Laboratories | 1 | $25 |
Products named: Ozempic, JARDIANCE, Kerendia, CAPLYTA, MOUNJARO, TZIELD, Heplisav-B, Rybelsus.
Industry payments across TX — which companies pay providers there.
